Vor Biopharma Inc (VOR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Bob Ang
Employees:
140
215 FIRST STREET, SUITE 430, CAMBRIDGE, MA 02142
617-655-6580

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 202.562 Million Shares Outstanding37.511 Million Avg 30-day Volume 67.799 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.5
Price to Revenue0.0 Debt to Equity0.0 EBITDA-76.539 Million
Price to Book Value1.1679 Operating Margin0.0 Enterprise Value45.477 Million
Current Ratio10.488 EPS Growth0.988 Quick Ratio10.009
1 Yr BETA 1.3506 52-week High/Low 18.52 / 3.83 Profit Margin0.0
Operating Cash Flow Growth-55.4643 Altman Z-Score2.29 Free Cash Flow to Firm -62.872 Million
View SEC Filings from VOR instead.

View recent insider trading info

Funds Holding VOR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VOR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
16,911 2022-06-14 1

PATTERSON MATTHEW R

  • Director
16,911 2022-06-14 1

BECKMAN DANIELLA

  • Director
16,911 2022-06-14 1

LUBNER DAVID CHARLES

  • Director
16,911 2022-06-14 1

PARMAR KUSH

  • Director
  • 10% Owner
16,911 2022-06-14 2

LUNDBERG SVEN ANTE

  • Director
16,911 2022-06-14 1

RESNICK JOSHUA

  • Director
16,911 2022-06-14 1

ANG ROBERT PRESIDENT AND CEO

  • Officer
  • Director
376,000 2022-02-01 1

CHAKRABORTY TIRTHA CHIEF SCIENTIFIC OFFICER

  • Officer
101,000 2022-02-01 2

SLAPAK CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
116,000 2022-02-01 1

JORGENSEN NATHAN D. CHIEF FINANCIAL OFFICER

  • Officer
135,000 2022-02-01 1

5AM VENTURES VI, L.P.

5AM PARTNERS VI, LLC

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

SCHWAB ANDREW J.

  • 10% Owner
6,361,723 2021-11-16 1

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
No longer subject to file 2021-02-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VOR BIOPHARMA INC VOR 2022-08-15 22:15:04 UTC -0.7502 3.0702 40000
VOR BIOPHARMA INC VOR 2022-08-15 21:45:04 UTC -0.7502 3.0702 40000
VOR BIOPHARMA INC VOR 2022-08-15 21:15:04 UTC -0.7502 3.0702 40000
VOR BIOPHARMA INC VOR 2022-08-15 20:45:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 20:15:03 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 19:45:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 19:15:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 18:45:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 18:15:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 17:45:04 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 17:15:03 UTC -0.7979 3.1179 40000
VOR BIOPHARMA INC VOR 2022-08-15 16:45:04 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 16:15:04 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 15:45:04 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 15:15:04 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 14:45:04 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 14:15:03 UTC -0.8507 3.1707 40000
VOR BIOPHARMA INC VOR 2022-08-15 13:45:04 UTC -1.1763 3.4963 40000
VOR BIOPHARMA INC VOR 2022-08-15 13:15:04 UTC -1.1763 3.4963 40000
VOR BIOPHARMA INC VOR 2022-08-15 12:45:04 UTC -1.1763 3.4963 40000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VOR -1600.0 shares, $-9664.0 2022-03-31 N-PORT

Elevate your investments